{"name":"Timber Pharmaceuticals Inc.","slug":"timber-pharmaceuticals-inc","ticker":"","exchange":"","domain":"timber.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TMB-001","genericName":"TMB-001","slug":"tmb-001","indication":"Onychomycosis (fungal nail infection)","status":"phase_3"}]}],"pipeline":[{"name":"TMB-001","genericName":"TMB-001","slug":"tmb-001","phase":"phase_3","mechanism":"TMB-001 is a topical antifungal agent designed to treat fungal skin infections by disrupting fungal cell membrane integrity.","indications":["Onychomycosis (fungal nail infection)","Other fungal skin infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOYzE4RU0tR1Nwb2MxaGp0Vmw2eEdyLVJMVGpYLVg4Ni1SbzlFUDA3VXRjMTVueGVjWVV4UE1tNlhlYlYxbW5NbFhCQ2drRHBUMm15MTltMTkyUG1Ea3lFekNmWkdaeGNIZ2F5dnRJN25BR3ZqYkctRV9kUVBlZDYwUUZlMUtuWEFZVUFOREJobHBOdERzLWQ0Wjh1V2hPLWk3aUww?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Ichthyosis Market Size in the 7MM is Expected to Experience Major Growth by 2034, estimates DelveInsight - openPR.com","headline":"Ichthyosis Market Size in the 7MM is Expected to Experience Major Growth by 2034, estimates DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQZ05qR05CVXl5OFB6cWFrSWQ1V2NhMHJMVU5xZVVZWnlDWEJvLVhPMjBHdkZEMmIwd0hNUFVFendwcDZFanFHTy1iWXgtRWFCRnVvU2JBZWpiNVd2LWkyNk95dFJnWFNObVI1b0djTFkzUnhPeG9HdnZJbHgyMy0zcXVoWVV1elRIcXc?oc=5","date":"2026-04-02","type":"trial","source":"HCPLive","summary":"ABCs in Dermatology: Late Breaking Data Spotlight at AAD 2026 - HCPLive","headline":"ABCs in Dermatology: Late Breaking Data Spotlight at AAD 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOVE90MGtHc0xEdnVFZlRNVHJLZjJ2M2VXUlJsSDV1SVBxSDh0WmprYTlya2k0Ym5PSEx0NmF1NGtSUUxSQjV4bmFLWVBLN0g4RGpVdmlvQjNMZGI0b2dQRmhUYl83MENKQjdDVXljZUlDVXdYTWJHeXJ1TmxtbzlSTkx4R0FEM2NpWVgtenNWS3gtRGZEcWFtNGxoS2RnczVJOHNObVRSdDY2Ym4wZklDZ0djUFV4QU83UXVweGJrTzE1YmNOZnB1Nk51cmQ5allJeElMaF9JMEZfeHJiR3lsWFQwTHEtVTdpNkJmZjJ2UDYyS3BhcHFGa3FYNjFTeUZIcWc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOcWJEWGNNdkZVTG91eFZROUxUT2xIUDBfNldXbWgyMWhIUzk5bEYwMjBEaW80VjVLSm85WjJXek5lN3llWWNoY0Y3NHdleFI1MVlpOGlvTXBzLVdLMTllelc0c0VhMU9CcjljT3djTzFuWUxQbUoySzYwSkRabVdsaTFvOThqaWJKQnJlZWZscmczbXJhU1VxNkRFa1JBVEZnakRDakZMc1dQZnRVdXhKcWJ1TWVibmtPTUNWSEVmdHg3a2VXRDd3MQ?oc=5","date":"2026-02-28","type":"trial","source":"Dermatology Times","summary":"Phase 3 Setback for TMB-001 Spurs Hopeful Out-Licensing of Vehicle in Congenital Ichthyosis - Dermatology Times","headline":"Phase 3 Setback for TMB-001 Spurs Hopeful Out-Licensing of Vehicle in Congenital Ichthyosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRFRjTEFKY3hYMU9JcGxhU3BNTi1vZzVjWmNWQng0Vk90Y3ktSFA0cU1ySkpjYjZoUGl5TUlLa0loZFBhU2N2bFU0S2swLVpBbjZKUmdpeUVza0pTZVVjZEppUXFwZlNNTEN2d3NRNjlPUkxmSTVDOWphRlhMY1piTmpwNXlzMlNDenBTSFd1R3hiV2MxWU54dDBucmFPRnY4eTZWQk5R?oc=5","date":"2024-08-22","type":"trial","source":"Clinical Trials Arena","summary":"Leo Pharma’s Timber bet falls flat following Phase III failure - Clinical Trials Arena","headline":"Leo Pharma’s Timber bet falls flat following Phase III failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNRXpheUVyVTB5UDU2NVpvQkJrRmcyQ3o5bDNOZm10bEVhM21BZjhDa3ljQTB6cHV3WERKYkg1SlBUZTBuOG9QandwTnVPVDZCcHl1dUZEcjBsOHl4Y2N5WUo4Q3A5TXpTVVNXek9obGZTOG5jb0E5c2RYbWhFN3pkXzhPSjlyVlN2RHM4YUpUU3laaUtrd1NGellxU29tSGplM1NXLS1TbzFVemZtZkxyNGNhUWN2VUtwX3dfdTFGN3FpQnpa?oc=5","date":"2024-01-23","type":"pipeline","source":"Dermatology Times","summary":"LEO Pharma Completes Key Asset Acquisition, Including TMB-001, From Timber Pharmaceuticals - Dermatology Times","headline":"LEO Pharma Completes Key Asset Acquisition, Including TMB-001, From Timber Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQbjdtRkl4M0Zobk5uYktGTmZpWmhsb09Ddm1sR2dVcXhMcWFKeTdxMGs2OWhHandXdEQ2a2JsVHZwMGw4NjduWnpKTG1Ddkg5QjFfTFlQWUJ6VVB0b2E1aERlOVJjMlJKMkNBN2dvaENfNlNybUtNY0JZRFgtcXE4cmYyenJuOGpKUHJOV3djZUM2NnJIRFNOclRaYWJobVhXcjB4a25aSjRRczNuM2hRcTZQTHZCVS00VnlKX2JGUEprbFdwQ2FxMWpPNUVkcjJ6d0NjRjBZblJWVGxCSkIyWlNtOTJucFRtWHE3Q3dnSndMUXAtY2Jfc2lmOVRwcGM?oc=5","date":"2024-01-22","type":"pipeline","source":"Lowenstein Sandler LLP","summary":"Lowenstein Represents Timber Pharmaceuticals as Special Corporate Counsel in Chapter 11 and Asset Sale to Leo Pharma A/S - Lowenstein Sandler LLP","headline":"Lowenstein Represents Timber Pharmaceuticals as Special Corporate Counsel in Chapter 11 and Asset Sale to Leo Pharma A/S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOYzlXalFSR3Z4M21QU3FjZTJBN0VOOFRSc215MzNfT2lMRVZKek9CZ001NDQyU0NtOE12VFZKNlFZeFVoZUhGcHMtdEc0LXEwODB3Ukk1YnNLeVdPM3hHS3Y2SmFNWmFFOTl4cUh2cjcyb0ktWkRKN0RvUzcxWEthLTdaRQ?oc=5","date":"2023-08-22","type":"deal","source":"finance.yahoo.com","summary":"Timber (TMBR) to Get Acquired by LEO Pharma for $36M, Stock Up - finance.yahoo.com","headline":"Timber (TMBR) to Get Acquired by LEO Pharma for $36M, Stock Up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPaTdrWExOU1ZkWEl3RkVLb3pwU0ZHN3lFQ2lpSG9HS2xZa29vRllLeXNvTDhGUENTMHV1RHBNeGJPQ0pGbnl3c3hoRV9sa0xzaWNBQ2JfR2dXZkxKWnVNZXItN2ZTRnJFMmhGLWtocE1CWUYxa28wRnJHZzlOdUJCZFhtYWlZSkVXVnpBRC1nZ2d2S1o5b3Rnc3pvYWtLVnE1V2FOUmF5blNPTGVESXVkWnhLbkUxOWRaLUszVkNDZURZZFE4eFlMQXlQTGlJcGpOYTQ0?oc=5","date":"2023-08-21","type":"deal","source":"Via Ritzau","summary":"LEO Pharma signs agreement to acquire Timber Pharmaceuticals - Via Ritzau","headline":"LEO Pharma signs agreement to acquire Timber Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPOC1yalpyVERfLV9ncjRLV1l1NEVqdXFzS0NRMV9XZGZMNTZZU01GdnBtaWkyQmFhYU96NUttV0hDUUJSQU5ad2xXbFFDN0c0a1JlaXJjY2ZNc0RLVkdoZTltbHVCQ2E4SktTSFRESlFrV1hjMnlDbEdqYTRVMHRUdUZNazlteHQ0V1VCVjQ2bFJDY0JjZ081TFV3NEZxaVMyU1FmRjFaUkNwODY4NWltQm1qb1Y3SDMzU2w3dnJhbFJiYWJyT0wyaWVKTGJhd0h0ekE?oc=5","date":"2023-04-14","type":"pipeline","source":"Healio","summary":"Topical isotretinoin ointment shows ‘reassuring’ efficacy, safety in congenital ichthyosis - Healio","headline":"Topical isotretinoin ointment shows ‘reassuring’ efficacy, safety in congenital ichthyosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOU3RfWXJGLUpvMEZBQXl5N3dZSTJXSUp4TWZfVnlGOU1TN2FjeVA3RUw3U0tvYmc2cF9LODc1WmZULW5CM0NXa1BuZm1uYkFHZDFsWmZDdjYtOG41MEpCa0xVd0F6S2Z0Um5rUW1aVHg3MlktTk5yQy0wbjRnTDVSN1NEdUMwdzBvTUl0alZFaGV6MEU1TThvdkpvd1A1UlNGb3dBa1pn?oc=5","date":"2020-05-18","type":"deal","source":"PR Newswire","summary":"Timber Pharmaceuticals Announces Merger Closing - PR Newswire","headline":"Timber Pharmaceuticals Announces Merger Closing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRXJpRnJzQmxXbjhWTElIY0FlWWJNb0JQOGZYa1k5eWt0RnpHdmZFUHRrVXQ3UHZ3TXpFVkxGdHlGMXRVUk5HczN4SE9MSlRPUFV4S0lPTmRGQjlUbkRTVWJKbXpYakl2UnZBYW9xNFNyZ096eG1QNWZWNUE5OWxwRk1sbTVSaGtvUlowTTdMRkVpdXhMVmF4WE5XSnVhcDBXU3lJSGhFMjY3NFd6YVpkUllTS2tieUVHdVV5SElVUHpOaWhLNGxQTQ?oc=5","date":"2020-01-28","type":"deal","source":"PR Newswire","summary":"BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement - PR Newswire","headline":"BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}